Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Molecular Karyotyping Combined with FISH Offers an Alternative to Chromosome Banding Analysis for Diagnostic Evaluation of Genome Complexity in Acute Myeloid Leukemia

A Borsatti, Elisabeth P. Nacheva, MD PhD

Blood (2019) 134 (Supplement_1): 5188.

https://doi.org/10.1182/blood-2019-131983

Published: 2019

Journal Articles

Identification of Genotype-Specific Therapeutic Vulnerabilities By Comparative Dynamic BH3 Profiling Analysis of Human and Murine CLL

Shanye Yin, PhD, Salma Parvin, PhD, Elisa Ten Hacken, PhD, Rebecca Valentin, MD, Heather Joyal, Laura Z. Rassenti, PhD, Emanuela M. Ghia, PhD, Thomas J. Kipps, MD PhD, Donna S Neuberg, ScD, Lili Wang, MD PhD, Matthew S. Davids, MD, Ruben D. Carrasco, MD PhD, Anthony G. Letai, MD PhD, Catherine J. Wu, MD

Blood (2019) 134 (Supplement_1): 4281.

https://doi.org/10.1182/blood-2019-127293

Published: 2019

Journal Articles

Emergence of a Novel Clinical Entity within Myelodysplastic Syndromes Marked By Absence of Quantifiable Terminal Erythroid Differentiation, More Profound Anemia and Significantly Worse Survival across All Prognostic Risk Categories

Abdullah Mahmood Ali, PhD, Yumin Huang, Ronald F Pinheiro, MD, Fumin Xue, PhD, Jingping Hu, PhD, Nicholas Iverson, BS, Daniela Hoehn, MDPhD, Diego Coutinho, BS, Joseph Lane, MD, Christopher D. Hillyer, MD, Naomi Galili, PhD, Joseph G. Jurcic, MD, Mohandas Narla, DSc, Xiuli An, MD PhD, Azra Raza, MD

Blood (2017) 130 (Supplement 1): 4244.

https://doi.org/10.1182/blood.V130.Suppl_1.4244.4244

Published: 2017

Journal Articles

A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory T-Cell Lymphomas

Blood (2016) 128 (22): 2991.

https://doi.org/10.1182/blood.V128.22.2991.2991

Published: 2016

Journal Articles

Association of MHC-II, PD-L1, and FoxP3 with Disease Status and Outcomes in Patients with Hodgkin Lymphoma

Santosha A. Vardhana, MD PhD, Neval Ozkaya, MD, Eri Matsuki, MD PhD MPH, Janine D. Pichardo, BS, Alison J. Moskowitz, MD, David J Straus, MD, Amanda R Copeland, RN, MSN, CNS, Ai Ni, PhD, Achim A Jungbluth, MD, Craig H Moskowitz, MD, Ahmet Dogan, MD PhD, Anas Younes, MD

Blood (2016) 128 (22): 1774.

https://doi.org/10.1182/blood.V128.22.1774.1774

Published: 2016

Journal Articles

PD-L1 Expression Identifies High Risk Diffuse Large B-Cell Lymphoma and Is Associated with Several Genomic Markers

Imran N Siddiqi, MD PhD, Venkata Thodima, PhD, Julia Friedman, PhD, Adames Violeta, Anil Tulpule, MD, Rita Shaknovich, MD PhD, Jane Houldsworth, PhD

Blood (2016) 128 (22): 153.

https://doi.org/10.1182/blood.V128.22.153.153

Published: 2016

Journal Articles

Foundation-One R -Heme Next Generation Sequencing of Hairy Cell Leukemia Variant Lymphocytes

John R. Pawloski, MD PhD, Brion Randolph, MD, Paulie Bajic, MD PhD

Blood (2016) 128 (22): 5289.

https://doi.org/10.1182/blood.V128.22.5289.5289

Published: 2016

Journal Articles

Analysis of Genomic Aberrations and Its Impact on Survival in Patients with Chronic Lymphocytic Leukemia (CLL) at the William Beaumont Hospital Cancer Center

Foluso Nelson Ogunleye, MD, Mohammed Ibrahim, MD, Leann Michelle Blankenship, MD, Siddhartha Yadav, MD, Tolulope Ifabiyi, Vonda Douglas, MD, Mark Micale, PhD, Elisa Quiroz, MD, Susanna S Gaikazian, MD, Michael Stender, MD, Marianne Terese Huben, DO, Joseph Anderson, MD, Ishmael Jaiyesimi, DO

Blood (2016) 128 (22): 5580.

https://doi.org/10.1182/blood.V128.22.5580.5580

Published: 2016

Journal Articles

A 220-Gene Targeted Next-Generation Sequencing Panel for the Detection of Variants in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma: Application to a Cohort of 85 Formalin-Fixed Paraffin-Embedded Diffuse Large B-Cell Lymphoma Biopsies

Julia Friedman, PhD, Asha Guttapalli, M.Sc., Charles Ma, PhD, Venkata Thodima, PhD, Raghavendra Padmanabhan, Sitharthan Kamalakaran, PhD, Imran N Siddiqi, MD PhD, Jane Houldsworth, PhD

Blood (2015) 126 (23): 1470.

https://doi.org/10.1182/blood.V126.23.1470.1470

Published: 2015

Journal Articles

Synergistic Targeting of Protein Translation and Inhibition of NOTCH Signaling in T-ALL

Marta Sanchez-Martin, PhD, Alberto Ambesi-Impiombato, MDPhD, Luyao Xu, Yue Qin, Daniel Herranz, PhD, Mukesh Bansal, PhD, Tiziana Girardi, Kim De Keersmaecker, Andrea Califano, PhD, Adolfo A. Ferrando, MD PhD

Blood (2015) 126 (23): 3719.

https://doi.org/10.1182/blood.V126.23.3719.3719

Published: 2015

Journal Articles

Targeting NF-κB with First in Class N-Quinoline Benzenesulfonamides (NQBS) Reveals Potent Activity in Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Matko Kalac, MD PhD, Michael Mangone, PhD, Alison Rinderspacher, PhD, Shi-Xian Deng, PhD, Luigi Scotto, PhD, Jeremie Vendome, PhD, Mukesh Bansal, PhD, Andrea Califano, PhD, Donald Landry, MD PhD, Owen A. O'Connor, MD PhD

Blood (2015) 126 (23): 4435.

https://doi.org/10.1182/blood.V126.23.4435.4435

Published: 2015

Journal Articles

Systematic Analysis of Cell-of-Origin, Sequencing and Genomic Imbalances Identifies a Distinct Subset of Rituximab Treated Diffuse Large B-Cell Lymphoma with an Inferior Survival

Rajan Dewar, MD PhD, Julia Friedman, PhD, Daniel Xia, MD, Timothy George Lens, Asha Guttapalli, M.Sc., Phillip Michaels, MD, Venkata Thodima, PhD, Sitharthan Kamalakaran, PhD, Jane Houldsworth, PhD, Robin Joyce, MD

Blood (2015) 126 (23): 3910.

https://doi.org/10.1182/blood.V126.23.3910.3910

Published: 2015

Journal Articles

Generation of Cell Lines Harboring SETBP1 Mutations By the Crispr/Cas9 System

Nozomu Kawashima, MD, Yusuke Okuno, MD PhD, Yuko Sekiya, MD, Xinan Wang, Yinyan Xu, PhD, Atsushi Narita, MD, Sayoko Doisaki, MD, Michi Kamei, MD, Hideki Muramatsu, MD PhD, Masahiro Irie, MD PhD, Asahito Hama, MD PhD, Yoshiyuki Takahashi, MD, PhD, Seiji Kojima, MD PhD

Blood (2014) 124 (21): 4622.

https://doi.org/10.1182/blood.V124.21.4622.4622

Published: 2014

Journal Articles

Genomic Complexity in Diffuse Large B-Cell Lymphoma Is Associated with p53 Expression and Inferior Survival

Charles Ma, PhD, Imran N Siddiqi, MD PhD, Yi Xie, MD PhD, Anil Tulpule, MD, Jane Houldsworth, PhD

Blood (2014) 124 (21): 3023.

https://doi.org/10.1182/blood.V124.21.3023.3023

Published: 2014

Journal Articles

Robust Assessment of Genomic Imbalance in Diffuse Large B-Cell Lymphoma Confirms Inferior Outcome Is Associated with Genomic Complexity and Identifies Potential Therapeutic Pathway Targets

Lizalynn Dias, PhD, Venkata Thodima, PhD, Asha Guttapalli, M.S., Geetu Mendiratta, PhD, Sergei I Syrbu, MD, Jane Houldsworth, PhD

Blood (2014) 124 (21): 2993.

https://doi.org/10.1182/blood.V124.21.2993.2993

Published: 2014

Journal Articles

PET Compared With CT As a Prognosticator After Rituximab Induction Therapy In Follicular Lymphoma: Report From The National Lymphocare Study

Ida Wong-Sefidan, MD, Michelle Byrtek, PhD, Xiaolei Zhou, MS, Jonathan W. Friedberg, MD, Christopher Flowers, MD, Brian K Link, MD, Andrew D. Zelenetz, MD, PhD, Keith L Dawson, DNP, RN, Erin G. Reid, MD, MS

Blood (2013) 122 (21): 4245.

https://doi.org/10.1182/blood.V122.21.4245.4245

Published: 2013

Journal Articles

Cross-Platform Assessment Of Genomic Imbalance In Diffuse Large B-Cell Lymphoma Identifies Novel Candidate Loci and Genes With Prognostic Value and Roles In Lymphomagenesis

Lizalynn Dias, Ph.D., Venkata Thodima, Ph.D., Geetu Mendiratta, Ph.D., Guttapalli Asha, M.S., Camille Gonzalez, Jocelyn C. Maragulia, Andrew D. Zelenetz, MD, PhD, Julie Teruya Feldstein, MD, Raju S.K. Chaganti, PhD, FACMG, Jane Houldsworth, PhD

Blood (2013) 122 (21): 4259.

https://doi.org/10.1182/blood.V122.21.4259.4259

Published: 2013

Journal Articles

Modeling Resistance To Tyrosine Kinase Inhibitors In TEL/ABL-Positive Acute Lymphoblastic Leukemia

Olga Zimmermannova, Jan Zuna, Katerina Machova Polakova, Libuse Lizcova, Zuzana Zemanova, I-Ming L. Chen, JH Frederik Falkenburg, Richard C. Harvey, PhD, Cheryl L. Willman, MD, Jan Trka, Marketa Zaliova

Blood (2013) 122 (21): 3826.

https://doi.org/10.1182/blood.V122.21.3826.3826

Published: 2013

Journal Articles

Safety and Efficacy Of Obinutuzumab (GA101) Plus CHOP Chemotherapy In First-Line Advanced Diffuse Large B-Cell Lymphoma: Results From The Phase 2 Gather Study (GAO4915g)

Andrew D Zelenetz, MD, PhD, Mehrdad Mobasher, MD, MPH, Luciano J Costa, MD, PhD, Ian Flinn, MD, PhD, Christopher R. Flowers, MD, MS, Mark S. Kaminski, MD, Thomas Sandmann, PhD, Kerstin Trunzer, PhD, Charlotte Vignal, MSc, PhD, Andres Forero-Torres, MD

Blood (2013) 122 (21): 1820.

https://doi.org/10.1182/blood.V122.21.1820.1820

Published: 2013

Journal Articles

A Proposed Prognostic Model For Overall Survival In The Oldest Old (>80 Years Old) Follicular Lymphoma Patients

Chadi Nabhan, MD, FACP, Michelle Byrtek, PhD, Keith L Dawson, DNP, RN, Xiaolei Zhou, MS, Brian K Link, MD, Jonathan W. Friedberg, MD, Andrew D. Zelenetz, MD, PhD, James R Cerhan, MD, PhD, Christopher R. Flowers, MD, MS

Blood (2013) 122 (21): 3058.

https://doi.org/10.1182/blood.V122.21.3058.3058

Published: 2013

NARROW

Molecular Karyotyping Combined with FISH Offers an Alternative to Chromosome Banding Analysis for Diagnostic Evaluation of Genome Complexity in Acute Myeloid Leukemia

Identification of Genotype-Specific Therapeutic Vulnerabilities By Comparative Dynamic BH3 Profiling Analysis of Human and Murine CLL

Emergence of a Novel Clinical Entity within Myelodysplastic Syndromes Marked By Absence of Quantifiable Terminal Erythroid Differentiation, More Profound Anemia and Significantly Worse Survival across All Prognostic Risk Categories

A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory T-Cell Lymphomas

Association of MHC-II, PD-L1, and FoxP3 with Disease Status and Outcomes in Patients with Hodgkin Lymphoma

PD-L1 Expression Identifies High Risk Diffuse Large B-Cell Lymphoma and Is Associated with Several Genomic Markers

Foundation-One R -Heme Next Generation Sequencing of Hairy Cell Leukemia Variant Lymphocytes

Analysis of Genomic Aberrations and Its Impact on Survival in Patients with Chronic Lymphocytic Leukemia (CLL) at the William Beaumont Hospital Cancer Center

A 220-Gene Targeted Next-Generation Sequencing Panel for the Detection of Variants in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma: Application to a Cohort of 85 Formalin-Fixed Paraffin-Embedded Diffuse Large B-Cell Lymphoma Biopsies

Synergistic Targeting of Protein Translation and Inhibition of NOTCH Signaling in T-ALL

Targeting NF-κB with First in Class N-Quinoline Benzenesulfonamides (NQBS) Reveals Potent Activity in Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Systematic Analysis of Cell-of-Origin, Sequencing and Genomic Imbalances Identifies a Distinct Subset of Rituximab Treated Diffuse Large B-Cell Lymphoma with an Inferior Survival

Generation of Cell Lines Harboring SETBP1 Mutations By the Crispr/Cas9 System

Genomic Complexity in Diffuse Large B-Cell Lymphoma Is Associated with p53 Expression and Inferior Survival

Robust Assessment of Genomic Imbalance in Diffuse Large B-Cell Lymphoma Confirms Inferior Outcome Is Associated with Genomic Complexity and Identifies Potential Therapeutic Pathway Targets

PET Compared With CT As a Prognosticator After Rituximab Induction Therapy In Follicular Lymphoma: Report From The National Lymphocare Study

Cross-Platform Assessment Of Genomic Imbalance In Diffuse Large B-Cell Lymphoma Identifies Novel Candidate Loci and Genes With Prognostic Value and Roles In Lymphomagenesis

Modeling Resistance To Tyrosine Kinase Inhibitors In TEL/ABL-Positive Acute Lymphoblastic Leukemia

Safety and Efficacy Of Obinutuzumab (GA101) Plus CHOP Chemotherapy In First-Line Advanced Diffuse Large B-Cell Lymphoma: Results From The Phase 2 Gather Study (GAO4915g)

A Proposed Prognostic Model For Overall Survival In The Oldest Old (>80 Years Old) Follicular Lymphoma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only